Arkolith/Insider Trading/PEAR/Form 4

O'Brien Ronan

GC, CCO & SecretaryPear Therapeutics, Inc. (PEAR) · full profile →Form 4 · filed Jan 24, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$14K
Net Open-Market Flow
-$14K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 20, 2023Sell(S)12K$1.13$14K19K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-23-001329) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML